| |
| |
|
| Insider
Information: |
Muehl Daniel W |
| Relationship: |
See Remarks |
| City: |
North Billerca |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
114,830 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,652,872 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
114,830 |
|
|
| Total
Value |
$1,652,872 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
26
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
23
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -1,216.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Repligen Corp |
RGEN |
CFO |
2006-01-19 |
10,000 |
2006-01-19 |
0 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2022-11-02 |
104,830 |
2017-03-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-03-05 |
4 |
S |
$29.29 |
$37,989 |
D/D |
(1,297) |
7,367 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,719 |
8,427 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-05-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
7,914 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-05-29 |
4 |
S |
$14.88 |
$4,032 |
D/D |
(271) |
7,643 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-06-04 |
4 |
S |
$15.07 |
$6,827 |
D/D |
(453) |
8,220 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-06-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,030 |
8,467 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-08-27 |
4 |
S |
$6.09 |
$1,456 |
D/D |
(239) |
8,528 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-08-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
8,767 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-09-04 |
4 |
S |
$5.21 |
$2,579 |
D/D |
(495) |
9,065 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,032 |
9,335 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-12-03 |
4 |
S |
$14.59 |
$6,799 |
D/D |
(466) |
9,934 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2019-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,031 |
10,188 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,497 |
27,388 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-02-04 |
4 |
S |
$8.41 |
$88,070 |
D/D |
(10,472) |
21,959 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-02-27 |
4 |
S |
$6.90 |
$1,925 |
D/D |
(279) |
22,227 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
22,506 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-03-03 |
4 |
S |
$7.20 |
$3,420 |
D/D |
(475) |
22,784 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,032 |
23,043 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,623 |
27,401 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-05-05 |
4 |
S |
$8.10 |
$17,925 |
D/D |
(2,213) |
26,194 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-05-27 |
4 |
S |
$6.91 |
$1,707 |
D/D |
(247) |
26,494 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
547 |
26,741 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-06-03 |
4 |
S |
$7.03 |
$3,304 |
D/D |
(470) |
27,054 |
0 |
% |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,030 |
27,310 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
See Remarks |
• – – |
2020-08-03 |
4 |
S |
$5.92 |
$14,836 |
D/D |
(2,506) |
30,172 |
0 |
% |
|
90 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
